 | Up a level |
Journal Article
Boegemann, Martin, Mikah, Phillip, Eminaga, Okyaz, Herrmann, Edwin, Papavassilis, Philipp Marius, Hinkelammert, Reemt, Semjonow, Axel, Schrader, Andres Jan and Krabbe, Laura-Maria (2015). Dynamic changes of alkaline phosphatase as surrogate for best clinical benefit and overall survival during very early abiraterone therapy compared to PSA-changes in bone metastatic castration resistant prostate cancer. J. Clin. Oncol., 33 (7). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Boegemann, Martin, Mikah, Phillip, Eminaga, Okyaz, Herrmann, Edwin, Papavassilis, Philipp Marius, Hinkelammert, Reemt, Semjonow, Axel, Schrader, Andres Jan and Krabbe, Laura-Maria (2015). Dynamic changes of alkaline phosphatase as surrogate for best clinical benefit and overall survival during very early abiraterone therapy compared to PSA-changes in bone metastatic castration resistant prostate cancer. J. Clin. Oncol., 33 (7). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Kluemper, Niklas, Ralser, Damian J., Zarbl, Romina, Schlack, Katrin, Schrader, Andres Jan, Rehlinghaus, Marc, Hoffmann, Michele J., Niegisch, Guenter, Uhlig, Annemarie, Trojan, Lutz, Steinestel, Julie, Steinestel, Konrad, Wirtz, Ralph M., Sikic, Danijel, Eckstein, Markus, Kristiansen, Glen, Toma, Marieta, Hoelzel, Michael, Ritter, Manuel, Strieth, Sebastian, Ellinger, Joerg and Dietrich, Dimo (2021). CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma. J. Immunother. Cancer, 9 (8). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426